NC LES 01 · 2026/27
PCQOF — Proactive Care Quality & Outcomes Framework
Previously known as ICCQ
Last update
1 October 2026
Data source
Clinical system
Refresh
Weekly · live
Next refresh
Auto · weekly
KPIs on target
2/23
21 below · 10 monitoring
Performance
44.6%
22 payment KPIs
Highest performing
CVD02
73.9% · target 64% · +9.9%
6,730 / 9,103
Lowest performing
CVD04
4.2% · target 92% · -87.8%
48 / 1,150
Most improved
—
Needs 2+ uploads
On target (2)Near target (4)Below target (20)No data (7)Mon= Monitoring only — no payment threshold
| Indicator⇅ | Target⇅ | Target activity⇅ | Performance %⇅ | Activity⇅ | Population⇅ | Shortfall⇅ | Status | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Complex Care | ||||||||||||
| CC01Sociofunctional assessment done (FY)▸ | 90% | 3,206 | 53.5% | 1,907 | 3,562 | 1,299 | Below | |||||
| CC02Carer info recorded (FY)▸ | 90% | 3,206 | 56.6% | 2,015 | 3,562 | 1,191 | Below | |||||
| CC03UCP care plan [PAY]Mon▸ | Monitoring | — | — | 79 | — | — | Monitoring | |||||
| CC04Comprehensive Medication Review (FY)Mon▸ | 80% | 2,850 | 51.3% | 1,826 | 3,562 | 1,024 | Below | |||||
| CC05Prognosis discussed FYMon▸ | 50% | 822 | 25.1% | 413 | 1,644 | 409 | Below | |||||
| CC06Anticipatory care planning FYMon▸ | 50% | 822 | 21.4% | 351 | 1,644 | 471 | Below | |||||
| Diabetes | ||||||||||||
| DM01T2DM 8 Care Processes Completed (FY)▸ | 78% | 17,430 | 48.2% | 10,764 | 22,346 | 6,666 | Below | |||||
| DM02Digital Retinal Screening (FY)▸ | 75% | 16,760 | 46.2% | 10,314 | 22,346 | 6,446 | Below | |||||
| DM03T2DM Triple Target Completed (FY)▸ | 43% | 8,909 | 29.2% | 6,046 | 20,718 | 2,863 | Below | |||||
| Mental Health | ||||||||||||
| MH01Antipsychotic monitoring (FY)▸ | 70% | 1,059 | 31.7% | 479 | 1,512 | 580 | Below | |||||
| MH02MH Depot Q1 2026-2027▸ | NIS | — | — | 199 | — | — | No data | |||||
| Respiratory | ||||||||||||
| RSP01COPD Annual Review [NIS]Mon▸ | Monitoring | — | 12.6% | 388 | 3,071 | — | Monitoring | |||||
| RSP02MRC 3+ Ref to Pul Rehab (01/04/24 - 31/03/27)▸ | 65% | 923 | 62.9% | 893 | 1,420 | 30 | Near | |||||
| Cardiovascular | ||||||||||||
| CVD01Primary Prevention Statins (FY)▸ | 70% | 16,872 | 79.1% | 19,066 | 24,102 | Met | Met | |||||
| CVD02Secondary Prevention Statins (FY)▸ | 64% | 5,826 | 73.9% | 6,730 | 9,103 | Met | Met | |||||
| CVD03CVD BP <140/90 (FY)▸ | 80% | 6,746 | 59.5% | 5,015 | 8,432 | 1,731 | Below | |||||
| CVD04AF patients on anticoagulants (FY)▸ | 92% | 1,058 | 4.2% | 48 | 1,150 | 1,010 | Below | |||||
| Renal | ||||||||||||
| CKD01CKD BP <140/90 (FY)▸ | 65% | 3,891 | 59.3% | 3,548 | 5,986 | 343 | Near | |||||
| CKD02CKD ACR >70 with BP <130/80 (FY) [NIS]Mon▸ | Monitoring | — | 44.5% | 3,265 | 7,338 | — | Monitoring | |||||
| CKD03CKD Proteinuria with ACEi/ARBs (FY)▸ | 81% | 1,357 | 5% | 84 | 1,675 | 1,273 | Below | |||||
| CKD04CKD G2/A3 or above with ACR urine (FY)▸ | 73% | 6,166 | 48.4% | 4,090 | 8,446 | 2,076 | Below | |||||
| CKD05CKD stages 1-5 recorded (FY)▸ | 19% | 1,330 | 11.1% | 776 | 6,996 | 554 | Below | |||||
| Care Planning | ||||||||||||
| CP02Smoking Intervention (FY)▸ | 90% | 8,135 | 76.5% | 6,914 | 9,038 | 1,221 | Near | |||||
| CP03Flu Vaccination (FY)Mon▸ | 74% | 33,693 | 0.1% | 60 | 45,530 | 33,633 | Below | |||||
| CP04Care Planning completed (FY)▸ | 70–75% | 41,103 | 33.8% | 18,515 | 54,803 | 22,588 | Below | |||||
| CP05Asthma Children Care Planning completed (FY)▸ | 72% | 2,029 | 46.8% | 1,319 | 2,818 | 710 | Below | |||||
| CP06Asthma only Adults Care Planning completed (FY)▸ | 70% | 6,397 | 30.8% | 2,815 | 9,138 | 3,582 | Below | |||||
| CP07Wider Determinants Enquiry Recorded (Apr 2025-Mar 2027)▸ | 80% | 44,177 | 74.9% | 41,361 | 55,221 | 2,816 | Near | |||||
| NDPP | ||||||||||||
| NDPP1bValid Referrals to NDPP (FY)Mon▸ | Monitoring | — | — | 324 | — | — | Monitoring | |||||
| ADHD | ||||||||||||
| ADHD01ADHD First Review DoneMon▸ | Monitoring | — | 40.9% | 780 | 1,908 | — | Monitoring | |||||
| ADHD02ADHD Second Review DoneMon▸ | Monitoring | — | 0% | — | 1,908 | — | Monitoring | |||||
| High Risk CVD | ||||||||||||
| HRR1High Risk CVD Annual Review done (15m)▸ | 70% | 2,371 | 35.3% | 1,194 | 3,386 | 1,177 | Below | |||||
| HRR2High Risk CVD prescribe statin and lifestyle advice▸ | 60% | 2,032 | 13.5% | 457 | 3,386 | 1,575 | Below | |||||
Data as of 1 October 2026 · Clinical system · Refreshed weekly